NEW YORK (GenomeWeb News) — Results of an ongoing collaboration between Lumera and the Harvard Institute of Proteomics have enabled the partners to try to use Lumera’s ProteomicProcessor biosensor to develop new diagnostics.
 
Since January, Harvard has served as a beta site for Lumera's platform. Researchers there have been trying to enable the ProteomicProcessor to analyze data from, their nucleic acid programmable protein array technology, also known as NAPPA.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.